Albert Stephen Kearney is a notable inventor based in Collegeville, PA (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 3 patents. His work focuses on developing innovative compounds that have the potential to improve medical treatments.

Latest Patents

One of Kearney's latest patents is for a compound titled (E)-3-[1-n-Butyl-5-[2-(2-carboxyphenyl)methoxy-4-chlorophenyl]-1H-pyrazol-4-yl]-2-[(5-methoxy-2,3-dihydrobenzofuran-6-yl)methyl]-prop-2-enoic acid monoargininyl salt. This invention relates to a new monoargininyl salt form of the endothelin receptor antagonist, which could have significant implications in treating various medical conditions.

Another notable invention is the six-sided pharmaceutical tablet, which showcases Kearney's innovative approach to drug formulation and delivery.

Career Highlights

Kearney is currently employed at SmithKline Beecham Corporation, where he continues to push the boundaries of pharmaceutical research. His work has been instrumental in developing new therapeutic agents that address unmet medical needs.

Collaborations

Throughout his career, Kearney has collaborated with talented individuals such as Ricky Holland and Joseph Robert Flisak. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Albert Stephen Kearney is a distinguished inventor whose contributions to pharmaceutical chemistry are noteworthy. His patents reflect a commitment to advancing medical science and improving patient care. His ongoing work at SmithKline Beecham Corporation promises to yield further innovations in the future.